Synthetic Notch CD123 and CLL1 chimeric antigen receptor T-cells (CAR-T) target acute myeloid leukemia and reduce off-tumor effects associated with CLL1 CAR-T cells

Rui Zhang, Na Chen, Mengnan Li, Qingxi Liu, Mingfeng Zhao · 2026

Read Synthetic Notch CD123 and CLL1 chimeric antigen receptor T-cells (CAR-T) target acute myeloid leukemia and reduce off-tumor effects associated with CLL1 CAR-T cells by Rui Zhang, Na Chen, Mengnan Li, Qingxi Liu, Mingfeng Zhao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13675449.txt.

Description

Rui Zhang and co-authors engineer safer cell therapy for acute myeloid leukemia in a 2026 study. CAR-T cells aimed at the CLL1 marker can kill this blood cancer, but CLL1 also sits on healthy neutrophils, so treatment can wipe out those key defenders. The team built a two-key lock to spare them.

Their synthetic Notch design fires only when a T cell meets both CD123 and CLL1, a pairing found on leukemia blasts. In dish tests the gated cells killed blasts harder and spared neutrophils more. They also showed fewer signs of exhaustion and kept a younger profile. In mouse models they expanded better and lasted longer. Dual gating may widen the safe use of CAR-T in this leukemia.

Catalog record

CREATORRui Zhang, Na Chen, Mengnan Li, Qingxi Liu, Mingfeng Zhao
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE61 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13675449

Browse the full library · About the Tower of Babel